JenaValve’s Trilogy Becomes First FDA-Approved TAVR Treatment For Aortic Regurgitation

 
• By Elizabeth Orr
  
JenaValve's Trilogy HeartValve is the first TAVR device that has been FDA-approved to treat aortic regurgitation. (Explode/Shutterstock)

More from Approvals

More from Medtech Insight